Le Lézard
Classified in: Science and technology
Subjects: Conference, Product/Service, Trade Show

Spok to Showcase the Latest Advancements to Top-Rated Secure Healthcare Communication and Collaboration Platform at HIMSS24


Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a leader in healthcare communications will showcase its top-rated clinical communication platform during HIMSS24. Spok experts will demonstrate the power of the new Spok Care Connect® hosted solution and the new reporting dashboards and user capabilities of Spok® Messenger in meeting place #MP162 throughout the conference, March 11-15, 2024, at the Orange County Convention Center in Orlando, Florida.

"HIMSS24 provides a wonderful opportunity to reconnect with customers and prospects to discuss how our latest advancements in our clinical communication technology provide better patient outcomes," said Vincent D. Kelly, chief executive officer of Spok Holdings, Inc. "Our rededicated focus on advancements to our healthcare communication platform, Spok Care Connect, helps thousands of healthcare organizations achieve this goal."

As part of the HIMSS24 conference, attendees can learn about the Spok Care Connect® hosted solution, which enables hospitals and clinics to access the power of Spok® applications remotely with a simple, recurring subscription plan. The base solution provides customers with enterprise web directory, on-call scheduling, and Spok Mobile® all managed by the same team that is trusted by over 2,200 hospitals, including the Best Hospitals. The Spok Care Connect hosted solution integrates with an organization's existing systems to deliver the right information quickly and securely to care team members who need to act on it.

Additionally, Spok experts will discuss how Spok Messenger's new reporting and dashboard capabilities provide a user-friendly way to showcase operational metrics for enterprise communications. This is an intelligent, FDA 510(k)-cleared software solution designed to send critical information and updates from an organization's various alert systems, such as nurse call and patient monitoring, to mobile staff on their communication devices. It establishes an enterprise-wide method for handling, prioritizing, and responding to key organizational events. The ability to reach mobile team members within seconds of a critical alert enhances overall workflow, staff productivity, and the well-being and safety of facility staff. With these new dashboards, organizations can access historical data to understand system health, performance, and staff response times to crucial patient safety or workflow matters.

To schedule a meeting with a Spok expert at HIMSS24, visit our website.

About Spok

Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK), headquartered in Alexandria, Virginia, is proud to be a global leader in healthcare communications. We deliver clinical information to care teams when and where it matters most to improve patient outcomes. Top hospitals rely on the Spok Care Connect® platform to enhance workflows for clinicians and support administrative compliance. Our customers send over 70 million messages each month through their Spok® solutions. Spok enables smarter, faster clinical communication.

Spok is a trademark of Spok Holdings, Inc. Spok Care Connect and Spok Mobile are trademarks of Spok, Inc.


These press releases may also interest you

at 03:29
Ericsson's annual general meeting on April 3, 2024 authorized the company to, in conjunction with the delivery of vested shares under the long-term variable compensation program 2021 ("LTV 2021"), prior to the annual general meeting in 2025, retain...

at 03:21
W3 Energy and Schierloh Engineering Group are pleased to announce a collaborative partnership to enhance the technical operation of wind farms across Germany. This strategic alliance will enable Schierloh Engineering GmbH to ensure uninterrupted...

at 03:05
In Q1 2024, LEO Pharma delivered a revenue growth of 13% in constant exchange rates (CER). The dermatology portfolio saw accelerated growth in revenue of 16%. The acquisition of TMB-001 to the treatment of congenital ichthyosis added a late-stage...

at 02:38
Sivers Semiconductors AB (STO: SIVE), a leading supplier of integrated chips and modules for advanced communications and sensor solutions for AI Photonics, SATCOM and 5G/6G today reported its first-quarter results for the fiscal year 2024. The...

at 02:22
Hansa Biopharma AB (publ), ("Hansa" or the "Company") (STO: HNSA) today announced that the company's registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby...

at 02:20
Vicore Pharma Holding (STO:VICO) Stockholm, May 3 2024- Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), publishes the interim...



News published on and distributed by: